Jason Baumgartner of BEKhealth Corporation Talks About The Current State of Research Operations in a COVID World with TrialSite
Jason CEO of BEKhealth Corporation talks with TrialSite about the current state of research operations in a COVID world. How COVID has impacted researcher capacity. How technology is improving patient pre-screening and enrollment. How sites can implement new technologies to alleviate manual processes and see more patients.
Read More
Real-World Evidence Doesn’t Need More Data. It Needs Better Reach.
Real-World Evidence Doesn't Need More Data. It Needs Better Data with Better Reach.The real-world evidence industry has spent two decades getting better at one thing: extracting more data from the historical record. Claims databases have grown deeper. EHR networks...
Why RWD-Informed Protocols Still Miss Enrollment Targets
Why RWD-Informed Protocols Still Miss Enrollment TargetsSponsors are using more RWD than ever, but enrollment is still failing 80% of the time. Here's why. The paradox sponsors keep running into RWD and clinical trial enrollment are increasingly discussed in...
First Analysis: Industry Forums Highlight 5 Key Themes in Pharma IT
Why “Eligible Patients” Aren’t Always Enrollable Patients
Why “Eligible Patients” Aren’t Always Enrollable PatientsThe industry’s reliance on eligibility as a proxy for enrollment is understandable. Protocols are built around eligibility criteria. Feasibility assessments often rely on structured EHR data and historical...